Troy Cox - Net Worth and Insider Trading

Troy Cox Net Worth

The estimated net worth of Troy Cox is at least $33 Million dollars as of 2025-03-05. Troy Cox is the CEO of Foundation Medicine Inc and owns about 242,068 shares of Foundation Medicine Inc (FMI) stock worth over $33 Million. Troy Cox is also the Director of Zymeworks Inc and owns about 7,500 shares of Zymeworks Inc (ZYME) stock worth over $95,625. Details can be seen in Troy Cox's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Troy Cox has not made any transactions after 2020-01-27 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.

GuruFocus Premium Membership
30 Years of Financial Data
Unlimited Filters in All-in-One Stock Screener
Earnings Calls & Stock Analysis
Customizable Stock Dashboard
Real-Time Insider Trading Alerts
8,000+ Institutional Investors’ 13F Holdings
Excel & Google Sheets Integration
Quick Customer Support
And Much More...

Transaction Summary of Troy Cox

To

Troy Cox Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Troy Cox owns 3 companies in total, including Zymeworks Inc (ZYME) , Foundation Medicine Inc (FMI) , and SomaLogic Inc (SLGC) .

Click here to see the complete history of Troy Cox’s form 4 insider trades.

Insider Ownership Summary of Troy Cox

Ticker Comapny Transaction Date Type of Owner
ZYME Zymeworks Inc 2022-12-21 director
FMI Foundation Medicine Inc 2018-07-31 director & President and CEO
SLGC SomaLogic Inc 2021-10-27 director

Troy Cox Latest Holdings Summary

Troy Cox currently owns a total of 2 stocks. Among these stocks, Troy Cox owns 242,068 shares of Foundation Medicine Inc (FMI) as of July 2, 2018, with a value of $33 Million and a weighting of 99.71%. Troy Cox also owns 7,500 shares of Zymeworks Inc (ZYME) as of January 27, 2020, with a value of $95,625 and a weighting of 0.29%.

Latest Holdings of Troy Cox

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FMI Foundation Medicine Inc 2018-07-02 242,068 137.00 33,163,316
ZYME Zymeworks Inc 2020-01-27 7,500 12.75 95,625

Holding Weightings of Troy Cox


Troy Cox Form 4 Trading Tracker

According to the SEC Form 4 filings, Troy Cox has made a total of 0 transactions in Foundation Medicine Inc (FMI) over the past 5 years. The most-recent trade in Foundation Medicine Inc is the sale of 1,402 shares on July 2, 2018, which brought Troy Cox around $191,597.

According to the SEC Form 4 filings, Troy Cox has made a total of 0 transactions in Zymeworks Inc (ZYME) over the past 5 years. The most-recent trade in Zymeworks Inc is the acquisition of 7,500 shares on January 27, 2020, which cost Troy Cox around $348,750.

Insider Trading History of Troy Cox

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Troy Cox Trading Performance

GuruFocus tracks the stock performance after each of Troy Cox's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Troy Cox is -13.17%. GuruFocus also compares Troy Cox's trading performance to market benchmark return within the same time period. The performance of stocks bought by Troy Cox within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Troy Cox's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Troy Cox

Average Return

LIMIT
Average return per transaction

Outperforming Transactions

LIMIT
0 out of 1 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -9.98 LIMIT LIMIT LIMIT LIMIT LIMIT
Relative Return to S&P 500(%) -1.81 LIMIT LIMIT LIMIT LIMIT LIMIT

Troy Cox Ownership Network

Ownership Network List of Troy Cox

No Data

Ownership Network Relation of Troy Cox

Insider Network Chart

Troy Cox Owned Company Details

What does Zymeworks Inc do?

Who are the key executives at Zymeworks Inc?

Troy Cox is the director of Zymeworks Inc. Other key executives at Zymeworks Inc include 10 percent owner Ecor1 Capital, Llc , director & Chair & CEO Kenneth Galbraith , and Chief Scientific Officer Paul Andrew Moore .

Zymeworks Inc (ZYME) Insider Trades Summary

Over the past 18 months, Troy Cox made no insider transaction in Zymeworks Inc (ZYME). Other recent insider transactions involving Zymeworks Inc (ZYME) include a net purchase of 2,282,688 shares made by Ecor1 Capital, Llc , a net sale of 81,195 shares made by Kenneth Galbraith , and a net sale of 30,999 shares made by Paul Andrew Moore .

In summary, during the past 3 months, insiders sold 89,601 shares of Zymeworks Inc (ZYME) in total and bought 2,282,688 shares, with a net purchase of 2,193,087 shares. During the past 18 months, 130,184 shares of Zymeworks Inc (ZYME) were sold and 2,282,688 shares were bought by its insiders, resulting in a net purchase of 2,152,504 shares.

Zymeworks Inc (ZYME)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Zymeworks Inc Insider Transactions

No Available Data

Troy Cox Mailing Address

Above is the net worth, insider trading, and ownership report for Troy Cox. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Troy Cox's mailing address is: Cambridge Ma 02141.